Atom | Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)

Due Dates: June 17, 2027 (Full application submission deadline)

Funding Amounts: Estimated total program funding: $1,000,000; R21 award mechanism; typical R21 awards are up to 2 years and $275,000 direct costs over the project period.

Summary: Supports early-stage dissemination and implementation (D&I) research in communication disorders within NIDCD mission areas to facilitate the adoption of evidence-based innovations.

Key Information: No foreign subawards/subcontracts allowed; see eligibility for updated NIH international collaboration policy.

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)

Sign in to see full grant listing